Texas Attorney General Joins Whistleblower Lawsuit against J & J
Two ground breaking legal actions in Texas to rein in out of control psychotropic drug prescribing will have nationwide reverberations.
-
-
Credibility Crisis: Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA
Credibility Crisis:Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA Thu, 16 Dec 2004 A credibility crisis in medical research is smoldering: like the Enron accounting scandal, the prescription-drug debacle is a matter of systemic corruption, including gross and widespread failure by the regulatory process. Unlike…
-
Research Protection: SCIENCE / Fed Paper
Research Protection: SCIENCE / Fed Paper Mon, 28 Oct 2002 SCIENCE magazine (below) reported about “the bumpy road” of Dr. Greg Koski’s tenure as director of the federal Office of Human Research Protections (OHRP), and how his resignation is being perceived by some. An article in The FEDERAL PAPER focused…
-
IOM Committee Considers Prison Research
IOM Committee Considers Prison Research Sun, 24 Jul 2005 Today¹s New York Times Magazine cover story, Planet of the Retired Chimpanzees By CHARLES SIEBERT, reports that chimpanzees who have served as subjects in biomedical research can look forward to being set free in one of 12 specially built chimp sanctuaries…
-
Safety of American Drugs Questioned – Assoc Press
Safety of American Drugs Questioned – Assoc Press Thu, 2 Dec 2004 In his CNN news program last evening, Lou Dobbs said the question is no longer whether something is wrong with the FDA’s performance in protecting the public from unsafe drugs–but whether the FDA can even be salvaged? The…
-
IOM Panel Misses the Point Test Subjects
Institute of Medicine (IOM) Panel Misses the Point re Test Subjects October 3, 2002 See also the following Institute of Medicine of the National Academy of Sciences documents: IOM Report: Responsible Research: A Systems Approach to Protecting Research Participants. Oct. 3, 2002 (Adobe Acrobat document) IOM Public Briefing – October…
-
Congress Bars EPA from accepting human pesticide data
Congress Bars EPA from accepting human pesticide data Thu, 28 Jul 2005 Thank you Senator Barbara Boxer and Representative Hilda Solis for leading the charge to stop the Environmental Protection Agency in its tracks. The EPA was formulating rules that would have oveturened the Nuremberg Code prohibition against using poisonous…
-
Forbes: Face of The Year: David Graham
Forbes: Face of The Year: David Graham Mon, 13 Dec 2004 Forbes magazine has named Dr. David Graham the Face of the Year’ for his “steadfast advocacy of drug safety and his willingness to blow the whistle on his bosses.” Dr. Graham took a courageous stand as a responsible…
-
Children Victimized | Foster Care | Gov. Medical Malfeasance | Immoral Experiments | NIH -- Ethics Violations
AIDS Drug Experiments on Foster Care Children – A National Scandal
Wed, 04 May 2005 Researchers Tested AIDS Drugs on Children, Associated Press On March 10, 2004, The Alliance for Human Research Protection filed a complaint with the FDA and the federal Office of Human Research Protection about a series of AIDS drug experiments conducted on New York City children in…
-
CBS News: Smallpox vaccine fiasco
CBS News: Smallpox vaccine fiasco Thu, 21 Aug 2003 Tonight CBS news will include an interview with Dr. Meryl Nass about the government’s questionable vaccine policy that coerces military personnel to be inoculated with highly controversial vaccines such as the smallpox vaccine. A report just issued by the Institute of…
-
National Institue AIDS Research–Professional Women Describe Sex Harassment – Conduct Unbecoming
National Institue AIDS Research–Professional Women Describe Sex Harassment – Conduct Unbecoming Mon, 11 Apr 2005 Just when the NIH announced that it was in the clear – citing a report issued (April 6) by a panel of the Institute of Medicine "exonerating" NIH and rejecting the allegations by Dr. Jonathan…
-
Concealed Data | Conflict of Interest | Corrupt Practices | Current Controversies | Investigations | Miscellaneous
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004 The Washington Post examines FDA’s record of surveillance and the evidence is clear: since 1992 when Congress required drug companies to pay users fees to the FDA, the agency’s focus changed from safety…